LONDON, August 22, 2018 /PRNewswire/ — Compass Pathways apothekegenerika.de, a
Read moreCompass Pathways Receives FDA Approval for Psilocybin Therapy Clinical Trial for Treatment-resistant Depression
Home » Medications »
Patient education urged to prevent opioid OD after sobriety
(HealthDay)—The American Medical Association (AMA) encourages patient education to raise
Read moreFDA Approves New Eylea (aflibercept) Injection Dosing Schedule in Wet Age-Related Macular Degeneration
TARRYTOWN, N.Y., Aug. 17, 2018 /PRNewswire/ — Regeneron Pharmaceuticals, Inc.
Read moreMore opioid users getting treatment since Medicaid expansion
(HealthDay)—The expansion of Medicaid that came along with the Affordable
Read moreCan I Cut Medication Patches in Half? — In Most Cases, No
How do transdermal patches work? Patches can be complex—they’re usually
Read moreDenmark’s Novo Nordisk buys UK insulin technology pioneer
Denmark’s Novo Nordisk, the world’s top insulin maker, said Friday
Read moreFDA Approves Galafold
August 10, 2018 — The U.S. Food and Drug Administration
Read moreFDA Approves Onpattro
August 10, 2018 — The U.S. Food and Drug Administration
Read moreSupport increases when opioid ‘safe consumption sites’ called ‘overdose prevention sites’
“Safe consumption sites,” where people can use pre-obtained drugs with
Read moreFDA approves medical device using shape memory technology
The Food and Drug Administration has approved the use of
Read more